Kestra Medical Technologies Quarterly Income Statement
NASDAQ: KMTSHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kestra Medical Technologies revenue and earnings
In the quarter ended Jul 31, 2026, Kestra Medical Technologies generated $31.0 million in revenue, up 59.9% from the same quarter a year earlier. Kestra Medical Technologies reported a net loss of $44.1 million, compared with a loss of $25.8 million a year earlier. Gross margin was 56.5% (up from 45.7%) and operating margin -121.6%.
Diluted earnings per share came in at -$0.75.
Summary generated from market data by MetaCap's automated system. Methodology
Kestra Medical Technologies income statement (quarterly)
| Quarter (USD) | Q1 20262026-07-31 | Q4 20262026-04-30 | Q3 20262026-01-31 | Q2 20252025-10-31 | Q1 20252025-07-31 | Q4 20252025-04-30 | Q3 20252025-01-31 | Q2 20252024-10-31 | Q1 20252024-07-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30.97M | 28.64M | 24.55M | 22.57M | 19.37M | 17.23M | 15.09M | 14.71M | 12.78M |
| Revenue growth (YoY) | +59.88% | +66.18% | +62.70% | +53.40% | +51.55% | — | — | — | — |
| Cost of Revenue | 13.47M | 12.96M | 11.65M | 11.14M | 10.52M | 9.60M | 8.54M | 8.88M | 8.58M |
| Gross Profit | 17.50M | 15.68M | 12.91M | 11.42M | 8.85M | 7.63M | 6.55M | 5.83M | 4.20M |
| Operating Expenses | 55.16M | 55.03M | 47.67M | 43.18M | 37.73M | 55.84M | 27.15M | 24.96M | 22.63M |
| Research & Development | 6.80M | 5.63M | 4.97M | 4.88M | 4.00M | 5.39M | 3.35M | 3.51M | 3.40M |
| Selling, General & Admin | 48.36M | 49.39M | 42.70M | 38.30M | 33.73M | 50.46M | 23.80M | 21.45M | 19.23M |
| Operating Income | -37.66M | -39.34M | -34.77M | -31.75M | -28.88M | -48.21M | -20.60M | -19.13M | -18.43M |
| Interest Expense | 1.93M | 1.84M | 1.89M | 1.90M | 1.91M | 1.76M | 1.78M | 2.32M | 1.87M |
| Other Income (Expense) | -272.00K | 319.00K | 359.00K | -891.00K | 2.83M | -2.69M | 15.00K | -40.00K | -48.00K |
| Pretax Income | -44.04M | -38.64M | -34.13M | -32.75M | -25.79M | -51.01M | -21.74M | -20.61M | -20.32M |
| Income Tax | 50.00K | 192.00K | 35.00K | 34.00K | 33.00K | 102.00K | 18.00K | 8.00K | 7.00K |
| Net Income | -44.09M | -38.84M | -34.17M | -32.78M | -25.83M | -52.05M | -21.51M | -20.37M | -19.88M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -0.75 | -0.68 | -0.61 | -0.64 | -0.50 | -1.57 | -1.25 | -1.19 | -1.12 |
| EPS (Diluted) | -0.75 | -0.68 | -0.61 | -0.64 | -0.50 | -1.57 | -1.25 | -1.19 | -1.12 |
| Shares Outstanding (Basic) | 58.57M | — | 55.85M | 51.38M | 51.30M | — | 19.89M | 19.89M | 19.89M |
| Shares Outstanding (Diluted) | 58.57M | — | 55.85M | 51.38M | 51.30M | — | 19.89M | 19.89M | 19.89M |
| EBITDA | -34.99M | -37.02M | -32.78M | -29.38M | -26.85M | -46.38M | -18.71M | -17.27M | -16.06M |
| Gross Margin | 56.50% | 54.76% | 52.57% | 50.63% | 45.69% | 44.29% | 43.39% | 39.63% | 32.86% |
| Operating Margin | -121.59% | -137.38% | -141.60% | -140.73% | -149.08% | -279.77% | -136.52% | -130.07% | -144.19% |
| Net Margin | -142.35% | -135.61% | -139.16% | -145.29% | -133.32% | -302.05% | -142.54% | -138.46% | -155.56% |
This table shows 9 quarterly periods of Kestra Medical Technologies's income statement, from Q1 2026 back to Q1 2025, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow KMTS's reporting calendar. What is a income statement?